05.02.2024 13:18:25
|
IDEXX Laboratories Expects Annual Earnings, Revenue To Climb
(RTTNews) - IDEXX Laboratories, Inc.(IDXX), a company focused on pet healthcare innovation, in its fourth-quarter financial report also initiated annual guidance for earnings and revenue, which are higher than last year.
For the full-year, the company expects net income per share of $10.84 to $11.33, up from last year's $10.06 per share.
On average, 12 analysts polled by Thomson Reuters expect the firm to earn $11 per share, for the year. Analysts' estimates typically exclude special items.
IDEXX projects annual revenue of $3.930 billion to $4.040 billion, up from last year's $3.660 billion. Analysts, on average, expect the firm to generate revenue of $3.97 billion.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
IDEXX Laboratories | 398,50 | -1,26% |